Confocal NL
PrivateLast Round
Early Funding
Oct 17, 2024
Total Funding Raised
$5.72M
Company Overview
Confocal NL is a diagnostic equipment company that develops and produces advanced confocal microscopes for live cell imaging.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Biotech Equipment, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Confocal NL Comparables
Compare Confocal NL with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genoa Instruments | 88% | |
| CrestOptics | 83% | |
| VisiTech International Ltd. | 82% |
Confocal NL Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 17, 2024 | ||||
| VC Round | Oct 27, 2022 | ||||
| Convertible Debt | Dec 24, 2021 | ||||
| Early Funding | Sep 11, 2018 | ||||
| Seed | Feb 4, 2016 |
Key People
Founding team and executive leadership
Confocal NL Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rabobank Startup & Scale-up team | Early Funding |
| ROM InWest | Early Funding |
| ECFG | Early Funding, VC Round |
| Nascent Ventures | Early Funding |
| UvA Ventures Holding BV | Seed |
| Innovatiefonds Noord-Holland | Convertible Debt, Early Funding |
| Netherlands Enterprise Agency | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2025
Christoph van der Reijden appointed as interim Chief Technology Officer.
- Sep 11, 2018
Led by Value Creation Capital.
Confocal NL Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Confocal NL's valuation, stock price, and market status.
Is Confocal NL a public or private company?
Confocal NL is a private company.
What is the current stock price of Confocal NL?
Confocal NL is a private company, so its shares have no public market price. Caplight tracks Confocal NL's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Confocal NL worth (valuation)?
Valuation information for Confocal NL is not publicly available.
Can I buy Confocal NL stock?
Confocal NL shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Confocal NL's last funding round?
Confocal NL's most recent funding round was Early Funding on October 17, 2024.
Who are the main investors in Confocal NL?
Key investors in Confocal NL include ROM InWest, ECFG, Nascent Ventures, Value Creation Capital.
Will Confocal NL IPO soon?
No public IPO plans have been announced for Confocal NL.
How can I track Confocal NL secondary market activity?
Caplight tracks bids, offers, and trades in Confocal NL's shares on secondary markets.